Two novel antifibrotics, HOE 077 and Safironil, modulate stellate cell activation in rat liver injury: Differential effects in males and females

American Journal of Pathology

Volumn 152, Issue 1, 1998, Pages 279-287

  Wang, Yuan Jen ^a,b   Wang, Shao Shean ^a   Bickel, Martin ^c   Guenzler, Volkmar ^c   Gerl, Martin ^c   Bissell, D Montgomery ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c SANOFI   (France)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; ANTIFIBROTIC AGENT; CARBON TETRACHLORIDE; COLLAGEN; LUFIRONIL; MESSENGER RNA; SAFIRONIL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; FEMALE; LIVER CELL CARCINOMA; LIVER INJURY; MALE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RAT; SEX DIFFERENCE; STELLATE CELL; VIRUS HEPATITIS;

ANIMALS; CARBON TETRACHLORIDE; COLLAGEN; FEMALE; LIVER; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; SEX CHARACTERISTICS;

EID: 0031975486     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Schuppan D: Structure of the extracellular matrix in normal and fibrotic liver: collagens and glycoproteins. Semin Liver Dis 1990, 10: 1-10
2. Bissell DM, Maher JJ: Hepatic fibrosis and cirrhosis. Hepatology: A Textbook of Liver Disease, ed 3, Edited by Zakim D, Boyer TD. Philadelphia, WB Saunders, 1996, pp 506-525
3. Prockop DJ, Kivirikko KI: Collagens: molecular biology, diseases, and potentials for therapy. Annu Rev Biochem 1995, 64:403-434
4. Hanauske-Abel HM: Fibrosis: representative molecular elements, a basic concept, and emerging targets for suppressive treatment. Hepatology: A Textbook of Liver Disease, ed 3. Edited by Zakim D, Boyer TD. Philadelphia, WB Saunders, 1996, pp 465-506
5. Hanauske-Abel HM, Gunzler V: A stereochemical concept for the catalytic mechanism of prolylhydroxylase: applicability to classification and design of inhibitors. J Theor Biol 1982, 94:421-455
6. Clement B, Chesne C, Satie AP, Guillouzo A: Effects of the prolyl 4-hydroxylase proinhibitor HOE 077 on human and rat hepatocytes in primary culture. J Hepatol 1991, 13(suppl 3):S41-S47
7. 4-induced fibrosis of the liver in rats. J Hepatol 1991, 13(suppl 3):S26-S34
8. Friedman SL, Roll FJ, Boyles J, Bissell DM: Hepatic lipocytes: the principal collagen-producing cells of normal rat liver. Proc Natl Acad Sci USA 1985, 82:8681-8685
9. Maher JJ, McGuire RF: Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo. J Clin Invest 1990, 86:1641-1648
10. Knittel T, Schuppan D, Meyer zum Buschenfelde KH, Ramadori G: Differential expression of collagen types I, III, and IV by fat-storing (Ito) cells in vitro. Gastroenterology 1992, 102:1724-1735
11. Mak KM, Leo MA, Lieber CS: Alcoholic liver injury in baboons: transformation of lipocytes to transitional cells. Gastroenterology 1984, 87:188-200
12. Friedman SL: Seminars in medicine of the Beth Israel Hospital, Boston: the cellular basis of hepatic fibrosis: mechanisms and treatment strategies. N Engl J Med 1993, 328:1828-1835
13. Lopez-de Leon A, Rojkind M: A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections. J Histochem Cytochem 1985, 33:737-743
14. Housset C, Rockey DC, Bissell DM: Endothelin receptors in rat liver: lipocytes as a contractile target for endothelin 1. Proc Natl Acad Sci USA 1993, 90:9266-9270
15. Bissell DM, Caron JM, Babiss LE, Friedman JM: Transcriptional regulation of the albumin gene in cultured rat hepatocytes: role of basement-membrane matrix. Mol Biol Med 1990, 7:187-197
16. Rockey DC, Chung JJ: Interferon gamma inhibits lipocyte activation and extracellular matrix mRNA expression during experimental liver injury: implications for treatment of hepatic fibrosis. J Invest Med 1994, 42:660-670
17. Jarnagin WR, Rockey DC, Koteliansky VE, Wang SS, Bissell DM: Expression of variant fibronectins in wound healing: cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis. J Cell Biol 1994, 127:2037-2048
18. Rhoads DD, Dixit A, Roufa DJ: Primary structure of human ribosomal protein S14 and the gene that encodes it. Mol Cell Biol 1986, 6:2774-2783
19. Rockey DC, Boyles JK, Gabbiani G, Friedman SL: Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture. J Submicrosc Cytol Pathol 1992, 24:193-203
20. Maher JJ, Zia S, Tzagarakis C: Acetaldehyde-induced stimulation of collagen synthesis and gene expression is dependent on conditions of cell culture: studies with rat lipocytes and fibroblasts. Alcohol Clin Exp Res 1994, 18:403-409
21. Gotwals PJ, Chi-Rosso G, Lindner V, Yang J, Ling L, Fawell SE, Koteliansky VE: The α1β1 integrin is expressed during neointima formation in rat arteries and mediates collagen matrix reorganization. J Clin Invest 1996, 97:2469-2477
22. Brocks DG, Steinert C, Gerl M, Knolle J, Neubauer HP, Gunzler V: A radioimmunoassay for the N-terminal propeptide of rat procollagen type III: application to the study of the uptake of the N-terminal propeptide of procollagen type III in isolated perfused rat liver Matrix 1993, 13:381-387
23. Brocks DG, Bickel M, Engelbart K: Type IV collagen antigens in serum of rats with experimental fibrosis of the liver. Alcohol Alcoholism 1987, Suppl 1:497-500
24. Palmerini CA, Fini C, Floridi A, Vedovelli A: High-performance liquid chromatographic analysis of free hydroxyproline and proline in blood plasma and of free and peptide-bound hydroxyproline in urine. J Chromatogr 1995, 339:285-292
25. Sakaida I, Matsumura Y, Kubota M, Kayano K, Takenaka K, Okita K: The prolyl 4-hydroxylase inhibitor HOE 077 prevents activation of Ito cells, reducing procollagen gene expression in rat liver fibrosis induced by choline-deficient L-amino acid-defined diet. Hepatology 1996, 23:755-763
26. Pinzani M, Failli P, Ruocco C, Casini A, Milani S, Baldi E, Giotti A, Gentilini P: Fat-storing cells as liver-specific pericytes: spatial dynamics of agonist-stimulated intracellular calcium transients. J Clin Invest 1992, 90:642-646
27. Abdel-Aziz G, Lebeau G, Rescan PY, Clement B, Rissel M, Deugnier Y, Campion JP, Guillouzo A: Reversibility of hepatic fibrosis in experimentally induced cholestasis in rat. Am J Pathol 1990, 137:1333-1342
28. Morcos SH, Khayyal MT, Mansour MM, Saleh S, Ishak EA, Girgis NI, Dunn MA: Reversal of hepatic fibrosis after praziquantel therapy of murine schistosomiasis. Am J Trop Med Hyg 1985, 34:314-321
29. Vater CA, Harris ED Jr, Siegel RC: Native cross-links in collagen fibrils induce resistance to human synovial collagenase. Biochem J 1979, 181:639-645
30. Mizobuchi Y, Shimizu I, Yasuda M, Matunaga H, Ma Y, Escobar E, Shiba M, Ito S: Suppressive effects of estradiol on dimethyl-nitro-samine-induced fibrosis of the liver in normal and castrated rats of both sexes. Hepatology 1996, 24:462A
31. Guattery JM, Faloon WW: Effect of estradiol on chronic active hepatitis. Ann Int Med 1996, 125:700
32. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993, 362:801-809
33. Mullins DE, Hamud F, Reim R, Davis HR: Inhibition of PDGF receptor binding and PDGF-stimulated biological activity in vitro and of intimal lesion formation in vivo by 2-bromomethyl-5-chlorobenzene sulfonylphthalimide. Arterioscler Thromb 1994, 14:1047-1055
34. Strauss BH, Chisholm RJ, Keeley FW, Gotlieb AI, Logan RA, Armstrong PW: Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circ Res 1994, 75:650-658
35. Bayard F, Clamens S, Meggetto F, Blaes N, Delsol G, Faye JC: Estrogen synthesis, estrogen metabolism, and functional estrogen receptors in rat arterial smooth muscle cells in culture. Endocrinology 1995, 136:1523-1529
36. Sullivan TR Jr, Karas RH, Aronovitz M, Faller GT, Ziar JP, Smith JJ, O'Donnell TF Jr, Mendelsohn ME: Estrogen inhibits the response-to-injury in a mouse carotid artery model. J Clin Invest 1995, 96:2482-2488
37. Shimizu I, Escobar E, Matunaga H, Ma Y, Shiba M, Mizobuchi Y, Yasuda M, Ito S: Fibrosuppressive effect of estradiol on rat Ito cells in primary culture. Hepatology 1996, 24:463A
38. Chu CM, Sheen IS, Lin SM, Liaw YF: Sex difference in chronic hepatitis B virus infection: studies of serum HBeAg and alanine aminotransferase levels in 10,431 asymptomatic Chinese HBsAg carriers. Clin Infect Dis 1993, 16:709-713
39. McMahon BJ, Alberts SR, Wainwright RB, Bulkow L, Lanier AP: Hepatitis B-related sequelae: prospective study in 1400 hepatitis B surface antigen-positive Alaska native carriers. Arch Intern Med 1990, 150:1051-1054
40. Poynard T, Bedossa P, Opolon P: Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997, 349: 825-832
41. Beasley RP: Hepatitis B virus as the etiologic agent in hepatocellular carcinoma: epidemiologic considerations. Hepatology 1982, 2:21S-26S
42. Resnick RH, Koff R: Hepatitis C-related hepatocellular carcinoma: prevalence and significance. Arch Int Med 1993, 153:1672-1677
43. Chen CJ, Liang KY, Chang AS, Chang YC, Lu SN, Liaw YF, Chang WY, Sheen MC, Lin TM: Effects of hepatitis B virus, alcohol drinking, cigarette smoking and familial tendency on hepatocellular carcinoma. Hepatology 1991, 13:398-406
44. Becker U, Deis A, Sorensen TIA, Gronbaek M, Borch-Johnsen K, Muller CF, Schnohr P, Jensen G: Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology 1996, 23:1025-1029
45. Wu J, Danielsson A: Inhibition of hepatic fibrogenesis: a review of pharmacologic candidates. Scand J Gastroenterol 1994, 29:385-391
46. Kershenobich D, Vargas F, Garcia-Tsao G, Perez Tamayo R, Gent M, Rojkind M: Colchicine in the treatment of cirrhosis of the liver. N Engl J Med 1988, 318:1709-1713
47. Wang YJ, Lee SD, Hsieh MC, Lin HC, Lee FY, Tsay SH, Tsai YT, Hu OYP, King ML, Lo KJ: A double-blind randomized controlled trial of colchicine in patients with hepatitis B virus-related postnecrotic cirrhosis. J Hepatol 1994, 21:872-877